Ayala Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q3 2010 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Ayala Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2010 to Q4 2023.
  • Ayala Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending December 31, 2023 was 11.9M shares, a 341% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 11.9M +9.2M +341% Dec 31, 2023 10-K 2024-04-16
Q3 2023 4.84M +3.02M +166% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 4.84M +3.02M +166% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 4.84M +3.02M +166% Mar 31, 2023 10-Q 2023-05-23
Q4 2022 2.7M -143M -98.1% Dec 31, 2022 10-K 2024-04-16
Q3 2022 1.82M -4.5K -0.25% Oct 31, 2022 10-K 2023-02-10
Q2 2022 1.82M -144M -98.8% Jul 31, 2022 10-Q 2022-09-13
Q1 2022 1.82M -144M -98.8% Apr 30, 2022 10-Q 2022-06-08
Q4 2021 146M +29.5M +25.4% Jan 31, 2022 10-Q 2022-03-17
Q3 2021 1.82M -76.3M -97.7% Oct 31, 2021 10-K 2023-02-10
Q2 2021 146M +82.9M +132% Jul 31, 2021 10-Q 2021-09-10
Q1 2021 146M +85.4M +142% Apr 30, 2021 10-Q 2021-06-14
Q4 2020 116M +55.9M +92.8% Jan 31, 2021 10-Q 2021-03-16
Q3 2020 78.1M +27.9M +55.5% Oct 31, 2020 10-K 2022-02-14
Q2 2020 62.7M +43.5M +226% Jul 31, 2020 10-Q 2020-09-10
Q1 2020 60.3M +52.2M +651% Apr 30, 2020 10-Q 2020-06-11
Q4 2019 60.2M -9.5M -13.6% Jan 31, 2020 10-Q 2020-03-13
Q3 2019 50.2M +45.6M +983% Oct 31, 2019 10-K 2021-01-22
Q2 2019 19.2M -33.6M -63.5% Jul 31, 2019 10-Q 2019-09-09
Q1 2019 8.02M -44.5M -84.7% Apr 30, 2019 10-Q 2019-06-10
Q4 2018 69.7M +27.5M +64.9% Jan 31, 2019 10-Q 2019-03-12
Q3 2018 4.63M -36.6M -88.8% Oct 31, 2018 10-K 2019-12-20
Q2 2018 52.8M +11.8M +28.8% Jul 31, 2018 10-Q 2018-09-10
Q1 2018 52.6M +12.2M +30.1% Apr 30, 2018 10-Q 2018-06-07
Q4 2017 42.3M +2.1M +5.22% Jan 31, 2018 10-Q 2018-03-12
Q3 2017 41.2M +1.15M +2.87% Oct 31, 2017 10-K 2019-01-11
Q2 2017 41M +6.49M +18.8% Jul 31, 2017 10-Q 2017-09-11
Q1 2017 40.4M +6.1M +17.8% Apr 30, 2017 10-Q 2017-06-06
Q4 2016 40.2M +6.17M +18.2% Jan 31, 2017 10-Q 2017-03-10
Q3 2016 40.1M +6.47M +19.2% Oct 31, 2016 10-K 2017-12-21
Q2 2016 34.5M +3.01M +9.56% Jul 31, 2016 10-Q 2016-09-08
Q1 2016 34.3M +6.79M +24.7% Apr 30, 2016 10-Q 2016-06-08
Q4 2015 34M +9.99M +41.6% Jan 31, 2016 10-Q 2016-02-26
Q3 2015 33.6M +14M +71.1% Oct 31, 2015 10-K 2017-01-09
Q2 2015 31.5M +12M +61.4% Jul 31, 2015 10-Q 2015-09-11
Q1 2015 27.5M +8.41M +44% Apr 30, 2015 10-Q 2015-06-15
Q4 2014 24M +10M +71.5% Jan 31, 2015 10-Q 2015-03-13
Q3 2014 19.6M +5.91M +43.1% Oct 31, 2014 10-K 2016-01-08
Q2 2014 19.5M +14.6M +298% Jul 31, 2014 10-Q 2014-09-09
Q1 2014 19.1M -554M -96.7% Apr 30, 2014 10-Q 2014-06-10
Q4 2013 14M -479M -97.2% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 13.7M +10.6M +334% Oct 31, 2013 10-K 2015-01-06
Q2 2013 4.9M -6.21M -55.9% Jul 31, 2013 10-Q 2013-09-16
Q1 2013 573M +286M +99.8% Apr 30, 2013 10-Q 2013-06-14
Q4 2012 493M +215M +77.1% Jan 31, 2013 10-Q/A 2013-03-25
Q3 2012 3.16M -247M -98.7% Oct 31, 2012 10-K 2014-01-29
Q2 2012 11.1M -229M -95.4% Jul 24, 2012 10-Q/A 2012-10-04
Q1 2012 287M Apr 30, 2012 10-Q/A 2012-10-18
Q4 2011 279M Jan 31, 2012 10-Q/A 2012-10-18
Q3 2011 250M +52.1M +26.3% Oct 31, 2011 10-K/A 2013-02-14
Q2 2011 240M Jul 31, 2011 10-Q 2011-09-12
Q3 2010 198M Oct 31, 2010 10-K 2012-01-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.